Cargando…
Restoration of Immune Responsiveness to Glioma by Vaccination of Mice with Established Brain Gliomas with a Semi-Allogeneic Vaccine
Prior studies had shown the clinical efficacy of a semi-allogeneic glioma vaccine in mice with lethal GL261 gliomas. This was confirmed in the present study. As subcutaneous vaccination resulted in protection against tumor in the brain, the present study assessed the impact of this vaccination of mi...
Autores principales: | Gattoni-Celli, Sebastiano, Young, M. Rita I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037743/ https://www.ncbi.nlm.nih.gov/pubmed/27598146 http://dx.doi.org/10.3390/ijms17091465 |
Ejemplares similares
-
Semi-allogeneic vaccines and tumor-induced immune tolerance
por: Yu, Jin, et al.
Publicado: (2009) -
Semi-allogeneic vaccine for T-cell lymphoma
por: Yu, Jin, et al.
Publicado: (2007) -
A therapeutic cancer vaccine against GL261 murine glioma
por: Kindy, Mark S., et al.
Publicado: (2016) -
Cellular and vaccine therapeutic approaches for gliomas
por: Hickey, Michelle J, et al.
Publicado: (2010) -
Brain Tsunamis in Human High-Grade Glioma: Preliminary Observations
por: Colpitts, Kayli, et al.
Publicado: (2022)